The Blood Glucose Monitoring Device market in the US has also witnessed the adoption of continuous glucose monitoring systems. However, the unwillingness of diabetes patients to use blood glucose monitoring devices could pose a challenge to the growth of this market, the Blood Glucose Monitoring Device Market in the US 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on the US market; it also covers the Blood Glucose Test Strips, Blood Glucose Meters, and Lancets market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Authored by: TechNavio
Published: July 2012
Format: Electronic - PDF by eMail
Number of Pages: #46
Table of Contents
1. Executive Summary
2. Introduction
3. Market Coverage
4. Market Landscape
4.1 Blood Glucose Test Strips Market in the US
4.2 Blood Glucose Meters Market in the US
4.3 Lancets Market in the US
5. Rate of Incidence and Prevalence
6. Vendor Landscape
7. Buying Criteria
8. Market Growth Drivers
9. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 LifeScan Inc.
13.2 Roche Diagnostics
13.3 Bayer Healthcare
13.4 Medtronic Inc.
13.5 Abbott Laboratories
14. Other Reports in this Series
List of Exhibits
1. Blood Glucose Monitoring Device Market in the US by Market Segmentation
2. Blood Glucose Monitoring Device Market in the US 2011–2015 (US$ million)
3. Blood Glucose Monitoring Device Market in the US by Key Market Segmentation 2011
4. Blood Glucose Test Strips Market in the US 2011–2015 (US$ million)
5. Blood Glucose Meters Market in the US 2011–2015 (US$ million)
6. Lancets Market in the US 2011–2015 (US$ million)
7. Blood Glucose Monitoring Device Market in the US by Forecast of Key Market Segmentation 2011–2015 (US$ million)
8. Blood Glucose Monitoring Device Market in the US by Market Forecast Segmentation (2011–2015)
9. Blood Glucose Monitoring Devices Market in the US by Treatment Methods
10. Major Complications among Diabetic Population in the US (percentage)
11. Blood Glucose Monitoring Device Market in the US by Vendor Segmentation 2011
Companies Mentioned
1. Bayer Healthcare
2. LifeScan Inc.
3. Medtronic Inc.
4. Roche Diagnostics
5. Abbott Laboratories,
6. Arkray Inc.
7. Braun Melsungen AG
8. Dexcom, GlySens Inc.
9. Hainice Medical Inc.
10. Nipro
11. Diagnostics Inc.
12. Nova Biomedical
13. Terumo Corporation.
2. LifeScan Inc.
3. Medtronic Inc.
4. Roche Diagnostics
5. Abbott Laboratories,
6. Arkray Inc.
7. Braun Melsungen AG
8. Dexcom, GlySens Inc.
9. Hainice Medical Inc.
10. Nipro
11. Diagnostics Inc.
12. Nova Biomedical
13. Terumo Corporation.